Walleye Trading’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Walleye Trading’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-16,500	Closed	-$66K	–	4900
2019 Q4	$66K	Buy	+16,500	New	+$77.5K	﹤0.01%	3723
2019 Q2	–	Sell	-500	Closed	-$3K	–	4758
2019 Q1	$3K	Sell	500 -7,000	-93%	-$72.3K	﹤0.01%	4079
2018 Q4	$101K	Buy	7,500 +2,800	+60%	+$47.2K	﹤0.01%	3885
2018 Q3	$91K	Buy	+4,700	New	+$100K	﹤0.01%	4261
2018 Q2	–	Sell	-10,700	Closed	-$216K	–	5107
2018 Q1	$216K	Buy	+10,700	New	+$250K	﹤0.01%	3437

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Walleye Trading's DPLO Position: Q1 2020 in Review

Walleye Trading sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 74,662 shares — an estimated $299K sold.

Walleye Trading first reported a position in DPLO in Q1 2018 and held it in 8 quarters. The position peaked at $707K in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Walleye Trading reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Walleye Trading sold 74,662 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $299K.
Walleye Trading first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2018 and held it in 8 quarters.
Walleye Trading's DIPLOMAT PHARMACY, INC. position peaked at $707K in Q2 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.